Open original FDA record ↗Recall record
- FDA identifier
- Z-0516-2009
- Company in FDA record
- Quantimetrix Corporation
- FDA classification date
- Jan 17, 2009
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
This recall was initiated due to efficacy concerns with the stabilized erythrocytes, leukocytes and lymphocytes contained in this product group.
Source facts
- Action
- The recall communication was initiated when customer both direct and distributors who have purchased the lots were mailed a recall notification letter dated June 8, 2008 with instructions which was sent via first class mail. Customers were requested to assist in the voluntary recall of the listed product and if any of the affected lots have been consumed please review their records to ensure that the obtained values conform to the stated specifications found in the lot specific product insert.
- Initiated
- 2007-06-01
- Root cause
- Employee error
- Terminated
- 2009-02-18
- Distribution
- Nationwide Distribution including states of AK, AR, AZ, CA, CO, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MN, MO, NC, ND, NH, NM, NY, OR, PA, SC, SD, TN, TX, VA, WA and WY.
- Recall number
- Z-0516-2009
- Recall status
- Terminated
- CDRH record ID
- 70970
- FDA classified
- 2009-01-17
- Recall event number
- 48190